Botulinum toxin type A therapy for cervical dystonia

Review (9 RCTs, n= 1144) suggests moderate certainty in the evidence that a single treatment session resulted in a clinically relevant reduction of cervical dystonia‐specific impairment, and pain, and high certainty that it is well tolerated, compared with placebo.

Source:

Cochrane Database of Systematic Reviews